CardioWise, Inc. specializes in advanced cardiovascular imaging technologies aimed at improving the diagnosis and management of heart diseases. Their primary product is a non-invasive imaging platform that utilizes proprietary algorithms to analyze cardiac function and structure. This technology enables healthcare providers to obtain detailed insights into a patient's cardiovascular health, facilitating early detection of potential issues and personalized treatment plans. The platform is designed to integrate seamlessly with existing healthcare systems, enhancing workflow efficiency and patient care.

In addition to their imaging platform, CardioWise is focused on developing innovative solutions that leverage artificial intelligence and machine learning to enhance diagnostic accuracy. Their research emphasizes the importance of data-driven approaches in cardiology, aiming to provide clinicians with actionable insights derived from comprehensive cardiac assessments. By combining cutting-edge technology with a strong scientific foundation, CardioWise is committed to advancing cardiovascular care and improving patient outcomes through enhanced diagnostic capabilities.

United States

CardioWise's non-invasive Cardiac Computed Tomography (cCT) analysis software produces an easy-to-understand 3D image model of the human heart.

535 West Research Center Boulevard Suite 135 M/S 2300, Fayetteville, Arkansas 72701, US

CardioWise, Inc.

Company Details